+34 603 445 673 
When a brand must recall products due to contamination or non-compliance, it isn’t just losing stock, it is facing a reputational crisis. Beyond the substantial legal costs, the erosion of public trust can be devastating. Similarly, unsubstantiated claims often spark regulatory scrutiny, leading to punitive revisions and lost credibility.
Every week, the EU Safety Gate (formerly RAPEX) publishes alerts on cosmetic product recalls due to health and safety concerns. These recalls underscore the crucial role of market surveillance and regulatory compliance across all countries and product categories within the cosmetics industry.
Not France or Germany, Italy leads cosmetic product recalls in the EU
It may come as a surprise, but Italy is currently one of the most active countries in cosmetic product recalls. In just one week, Italian authorities withdrew 82 cosmetic and personal care products, many of which still include:
- Lilial (Butylphenyl Methylpropional), banned in the EU in 2022 for reproductive toxicity.
- HICC (Hydroxyisohexyl 3-cyclohexene Carboxaldehyde), banned in 2019 and associated with allergic skin reactions.
These substances were once widely used in fragrances and personal care products. Their withdrawal reflects the EU’s strict approach to ingredient safety and evolving regulations.
Global cases: major cosmetic recalls beyond Europe
The EU is not working alone in this field. Cosmetic product recalls are increasing worldwide as authorities strengthen enforcement, improve detection methods and rely more heavily on post-market surveillance data. In many cases, recalls are no longer triggered only by inspections, but by consumer complaints, laboratory findings, or cross-border alerts between regulators.
United States. MoCRA in Action
In the United States, cosmetic oversight is carried out by the Food and Drug Administration. With the entry into force of MoCRA, the regulatory framework has been updated to strengthen market surveillance and enforcement tools available to the authority.
When safety concerns arise, recalls may follow findings related to product composition, contamination, or labelling non-compliance. In practice, many issues identified in the U.S. mirror those seen in EU Safety Gate notifications, such as the presence of prohibited substances, microbiological risks, or inadequate product documentation.
From a preventive perspective, the same principles applied in the EU remain relevant: up-to-date ingredient reviews, adequate safety substantiation, and traceability across the supply chain.
United Kingdom. Post-Brexit Enforcement
After Brexit, cosmetic products placed on the UK market fell under national enforcement, coordinated by the Office for Product Safety and Standards. Although the UK regulatory framework is still largely aligned with EU cosmetic rules, enforcement is now carried out independently.
Recalls in the UK are often linked to administrative or regulatory non-compliance, particularly for imported products. Issues such as incorrect labelling, missing UK-specific information, or failure to meet national notification requirements can lead to market withdrawals.
For companies operating in both the EU and UK, this reinforces the importance of managing compliance separately and avoiding assumptions of automatic regulatory equivalence.
Canada. Ingredient Restrictions and Consumer Safety
In Canada, cosmetic compliance is supervised by Health Canada, with a strong focus on ingredient control through the Cosmetic Ingredient Hotlist. Market surveillance activities may result in recalls when products are found to contain restricted substances or do not meet national safety expectations.
As in the EU, many Canadian recalls are linked to formulas that have not been updated following regulatory changes or to insufficient ingredient monitoring over time. This highlights the importance of continuous regulatory review rather than one-off compliance checks.
Why cosmetic product recalls are increasing
Product recalls are becoming more frequent due to a combination of stricter regulations, improved detection methods, and growing consumer awareness.
Many recalls stem from undisclosed or banned ingredients that were not properly checked against regional lists. Others result from contamination (microbiological or chemical) during manufacturing, or from misleading or incomplete labelling that fails to comply with local requirements. Furthermore, an increasing number of adverse reactions are being reported post-launch, putting additional pressure on brands to react quickly or face regulatory consequences.
How to prevent cosmetic recalls
Preventing a recall starts long before a product reaches the shelves. Brands must ensure that every ingredient is thoroughly reviewed against the most current regulatory frameworks in all markets of sale, whether it’s the EU’s annexes, the UK’s post-Brexit regulations, MoCRA in the U.S., or Health Canada’s Hotlist.
Labelling must be accurate, complete, and meet bilingual or specific formatting requirements when applicable. Safety assessments and stability studies must not be treated as formalities, but as essential checkpoints.
Equally important is establishing a robust cosmetovigilance or Market Surveillance system to monitor consumer feedback and adverse reactions, allowing for early detection of issues.
Don't let a recall damage your brand
At Cosmeservice, we help companies proactively defend their products through regulatory support, formula review, and ongoing cosmetovigilance. We’ve partnered with cosmetics leaders for more than 13 years to bring regulatory knowledge and compliance excellence into their operations, turning regulatory hurdles into growth accelerators.
Whether you operate in the EU, the USA, the UK, or the Canadian market, our team ensures your cosmetic products meet current safety standards, reducing the risk of regulatory sanctions and brand damage.
These incidents are great reminders that in cosmetics manufacturing, compliance isn’t an option; it has to be the core, the mindset. Brands that prioritise regulatory compliance expand faster, protect trust better, and outlast their competition.
Protect your reputation and avoid costly cosmetic product recalls with the support of Cosmeservice. Contact us today: info@cosmeservice.com
FAQs
What is the EU Safety Gate and how does it relate to cosmetic recalls?
The EU Safety Gate (formerly RAPEX) is the European Union’s rapid alert system for dangerous non-food products, including cosmetics. It publishes weekly alerts when national authorities identify unsafe or non-compliant products, including those withdrawn or recalled from the market.
Why does Italy have so many cosmetic product recalls in the EU?
Italy’s high number of recalls generally reflects active market surveillance rather than worse compliance overall. Italian authorities frequently withdraw products found to contain substances long banned in the EU, such as Lilial and HICC, often due to outdated formulas or non-compliant imports.
Does MoCRA increase the risk of cosmetic recalls in the United States?
MoCRA strengthens the FDA’s market surveillance and enforcement tools, meaning issues related to composition, contamination, or labelling are more likely to be identified. This raises the practical risk of recalls for brands that have not updated their compliance practices.
Is a product compliant in the EU automatically compliant in the UK?
No. Since Brexit, UK enforcement is carried out independently by the Office for Product Safety and Standards. Even though the frameworks remain largely aligned, brands must manage EU and UK compliance separately to avoid recalls linked to missing UK-specific information.
What is the most common cause of cosmetic product recalls?
Common causes include the presence of undisclosed or banned ingredients, microbiological or chemical contamination during manufacturing, and misleading or incomplete labelling that fails to meet local requirements.
How can a cosmetic brand reduce the risk of a recall?
Brands should continuously review ingredients against current regulations in every market of sale, keep labelling accurate and complete, treat safety assessments as essential rather than a formality, and maintain an active cosmetovigilance system to catch adverse reactions early.
